Tumour-Targeted and Redox-Responsive Mesoporous Silica Nanoparticles for Controlled Release of Doxorubicin and an siRNA Against Metastatic Breast Cancer [Retraction]
International Journal of Nanomedicine, May 2022
Jialang Zhuang, Siqi Chen, Ye Hu, Fan Yang, Qin Huo, Ni Xie
The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
|Practitioners (doctors, other healthcare professionals)||1||100%|
The data shown below were compiled from readership statistics for 1 Mendeley reader of this research output. Click here to see the associated Mendeley record.
|Readers by professional status||Count||As %|
|Student > Master||1||100%|
|Readers by discipline||Count||As %|
|Agricultural and Biological Sciences||1||100%|
Attention Score in Context
This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 23 May 2022.
All research outputs
of 23,312,088 outputs
Outputs from International Journal of Nanomedicine
of 3,885 outputs
Outputs of similar age
of 442,486 outputs
Outputs of similar age from International Journal of Nanomedicine
of 55 outputs
Altmetric has tracked 23,312,088 research outputs across all sources so far. This one is in the 22nd percentile – i.e., 22% of other outputs scored the same or lower than it.
So far Altmetric has tracked 3,885 research outputs from this source. They receive a mean Attention Score of 4.4. This one is in the 28th percentile – i.e., 28% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 442,486 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 32nd percentile – i.e., 32% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 55 others from the same source and published within six weeks on either side of this one. This one is in the 45th percentile – i.e., 45% of its contemporaries scored the same or lower than it.